NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

I think the standard is lower there with compassionate, but I don’t disagree. Perhaps what is more telling is that LP finally pulled the trigger on submitting an MAA for regulatory inspection. LP would not have done that without minimizing risks from every conceivable angle and some level of educated assurances from former regulators who are consultants. IMO, even continuing trial maturation, which no one really thinks about anymore, likely buttresses DCVax-l’s prospects.